FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

556001000001105: Depo-Provera Oncology 495mg/3.3mL injection


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2004. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    4561601000001114 Depo-Provera Oncology 495mg/3.3mL injection en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    8438001000001114 Depo-Provera 495mg/3.3mL injection en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    8438101000001110 Depo-Provera Oncology 495mg/3.3mL injection en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Depo-Provera Oncology 495mg/3.3mL injection Is a Medroxyprogesterone acetate 495mg/3.3mL injection false Inferred relationship Existential restriction modifier
    Depo-Provera Oncology 495mg/3.3mL injection Availability Discontinued product false Additional relationship Existential restriction modifier
    Depo-Provera Oncology 495mg/3.3mL injection NHS prescribing status NHS prescribable false Additional relationship Existential restriction modifier
    Depo-Provera Oncology 495mg/3.3mL injection Legal category Prescription Only Medicine false Additional relationship Existential restriction modifier
    Depo-Provera Oncology 495mg/3.3mL injection CSM recommendation to report adverse reactions Report only serious adverse reactions to the Committee on Safety of Medicines false Additional relationship Existential restriction modifier
    Depo-Provera Oncology 495mg/3.3mL injection Product name type Brand name false Additional relationship Existential restriction modifier
    Depo-Provera Oncology 495mg/3.3mL injection Has active ingredient Medroxyprogesterone false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group

    This concept is not in any reference sets

    Back to Start